Skip to content

The Polymerase Chain Reaction (PCR) Analysis of Nasal Polyps for Fungal DNA

PCR Analysis of Nasal Polyps for Fungal DNA

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00739921
Enrollment
260
Registered
2008-08-22
Start date
2006-06-30
Completion date
2015-05-31
Last updated
2019-12-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nasal Polyps, Sinusitis

Keywords

PCR Analysis, Allergic fungal sinusitis, Chronic rhinosinusitis, Nasal Polyps

Brief summary

The objective of this study is to determine whether the amount or type of fungal DNA present in the nose and home environment can be correlated with the outcomes of the following quality of life (QOL) instruments: Medical Outcomes Study 36-item Short Form (SF-36) and the Sino-Nasal Outcomes Study - 20 Questions (SNOT-20).

Detailed description

The objective of this study is to determine whether the amount or type of fungal DNA present in the nose and home environment can be correlated with the outcomes of the following quality of life (QOL) instruments: Medical Outcomes Study 36-item Short Form (SF-36) and the Sino-Nasal Outcomes Study - 20 Questions (SNOT-20). The study design involves case control Polymerase Chain reaction (PCR) analysis of nasal mucosal swabs, saliva swabs, blood serum, and home vacuum cleaner bags in patients with sinusitis and normal controls. The hypothesis is that the quantity and type of fungal DNA present in the nose and home environment are directly correlated with quality of life. Our research aims to both quantify the amount of fungi present in the nasal mucosa as well as to measure the severity of the patient's chronic rhinosinusitis (CRS) as a function of SNOT-20 and SF-36 outcomes questionnaires. We hypothesize that the amount and type of fungi present in the nose and home environment will correlate with the severity of the patients' symptoms of CRS.

Interventions

PROCEDURENasal swab under endoscopic guidance

After the application of pontocaine and neosynephrine spray, the following will be done: * A small sponge applicator will be used to swab the inside of your mouth for saliva collection * A blood sample (6cc - one tube) will be collected * A small brush applicator called a cytology brush and an instrument called an endoscope will be used to swab the inside of your nose (middle meatus) * Subjects will be asked to complete 2 standard quality of life questionnaires regarding how much your symptoms bother you * You will be asked to bring in a vacuum cleaner bag from home at a follow-up appointment which will be swabbed as well The samples will be refrigerated and analyzed using PCR to detect and speciate fungus.

Sponsors

Environmental Protection Agency (EPA)
CollaboratorFED
University of California, San Francisco
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Subjects with no sinus disease and subjects with chronic rhinosinusitis.

Exclusion criteria

* Immunocompromise * Pregnancy * Minors

Design outcomes

Primary

MeasureTime frame
Quality of life (QOL) instruments: Medical Outcomes Study 36-Item Short Form (SF-36) and the Sino-Nasal Outcomes Study- 20 questions (SNOT-20).During the course of outpatient visit

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026